|
Market Closed -
NSE India S.E.
15:05:07 23/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 20.91 INR | -0.43% |
|
-5.34% | -22.18% |
| Market Cap | 1.15B 12.16M 10.86M 10.03M 9.09M 17.01M 17.29M 121M 47.79M 605M 45.64M 44.67M 1.91B | P/E 2025 |
14.1x | P/E 2026 | 61.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.57B 16.49M 14.73M 13.6M 12.33M 23.06M 23.45M 164M 64.81M 820M 61.89M 60.57M 2.59B | EV / Sales 2025 |
1.16x | EV / Sales 2026 | 0.47x |
| Free-Float |
90.84% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -0.43% | ||
| 1 week | -5.34% | ||
| Current month | -8.21% | ||
| 1 month | -8.85% | ||
| 3 months | -14.37% | ||
| 6 months | -23.96% | ||
| Current year | -22.18% |
| 1 week | 19.16 | 22.35 | |
| 1 month | 19.16 | 23.49 | |
| Current year | 15.2 | 29.9 | |
| 1 year | 15.2 | 43.85 | |
| 3 years | 15.2 | 151.45 | |
| 5 years | 15.2 | 151.45 | |
| 10 years | 2.58 | 216.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 04/05/2017 | |
| Director of Finance/CFO | - | 20/05/2021 | |
Aman Purohit
CMP | Compliance Officer | - | 25/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | 04/05/2017 | |
| Director/Board Member | 54 | - | |
| Director/Board Member | 44 | 04/05/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.43% | -5.34% | -51.69% | -74.83% | 12.16M | ||
| -2.54% | +1.31% | +55.10% | +120.84% | 1,135B | ||
| -1.42% | +3.23% | +37.07% | +74.26% | 636B | ||
| +0.16% | +0.08% | +25.14% | +97.36% | 505B | ||
| -0.31% | +3.09% | +43.92% | +64.55% | 378B | ||
| -1.34% | -0.47% | +66.63% | +40.56% | 358B | ||
| -0.68% | +2.65% | +22.46% | +51.48% | 295B | ||
| -1.20% | +3.04% | +2.62% | +26.97% | 266B | ||
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | ||
| -0.73% | -0.10% | +29.24% | +101.19% | 193B | ||
| Average | -0.64% | +1.42% | +28.05% | +56.32% | 400.44B | |
| Weighted average by Cap. | -0.26% | +2.66% | +40.99% | +82.13% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.93B 30.82M 27.52M 25.42M 23.04M 43.11M 43.82M 306M 121M 1.53B 116M 113M 4.83B | 2.7B 28.46M 25.42M 23.48M 21.28M 39.81M 40.47M 283M 112M 1.42B 107M 105M 4.46B |
| Net income | 251M 2.64M 2.36M 2.18M 1.97M 3.69M 3.75M 26.22M 10.38M 131M 9.91M 9.7M 414M | 14.17M 149K 133K 123K 112K 209K 212K 1.48M 587K 7.42M 560K 548K 23.4M |
| Net Debt | 127M 1.34M 1.2M 1.11M 1M 1.87M 1.91M 13.3M 5.27M 66.65M 5.03M 4.92M 210M | 411M 4.33M 3.87M 3.57M 3.24M 6.06M 6.16M 42.99M 17.02M 215M 16.25M 15.91M 679M |
Employees
500
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | ₹20.91 | -0.43% | 40,139 |
| 22/10/26 | ₹21.00 | -0.47% | 62,006 |
| 21/10/26 | ₹21.10 | -3.03% | 23,032 |
| 19/10/26 | ₹21.76 | -1.49% | 19,900 |
| 16/10/26 | ₹22.09 | -0.18% | 13,444 |
- Stock Market
- Stocks
- BALAXI Stock
Select your edition
All financial news and data tailored to specific country editions
















